Marc Deloger
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Long-Term Effects of COVID-19
Papers in
-
- Cancer Genomics and Diagnostics 8
- Oncology 8
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Marie‐Agnès Petit (1 shared paper)Meriem El Karoui (1 shared paper)Steven C. Le Comber (1 shared paper)Richard A. Nichols (1 shared paper)Andrew Rowland Leitch (1 shared paper)Marie‐Angéle Grandbastien (1 shared paper)Michael Chester (1 shared paper)Petr Novák (1 shared paper)
- Journals
- Annals of Oncology (5 papers)Cancer Discovery (3 papers)Clinical Cancer Research (3 papers)British Journal of Cancer (2 papers)Nature Communications (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Marc Deloger
42 papers receiving 2.5k citations
Marc Deloger's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 372
- Neurology 190
- Oncology 581
- Infectious Diseases 407
- Immunology 417
Countries citing papers authored by Marc Deloger
This map shows the geographic impact of Marc Deloger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Deloger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Deloger more than expected).
Fields of papers citing papers by Marc Deloger
This network shows the impact of papers produced by Marc Deloger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Deloger. The network helps show where Marc Deloger may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Deloger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 Hit paper breakdown → | 2020 | 620 |
| 2 | Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis Hit paper breakdown → | 2016 | 314 |
| 3 | Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial Hit paper breakdown → | 2023 | 294 |
| 4 | Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration Hit paper breakdown → | 2022 | 248 |
| 5 | 2011 | 143 | |
| 6 | 2008 | 130 | |
| 7 | 2017 | 108 | |
| 8 | 2016 | 98 | |
| 9 | 2020 | 74 | |
| 10 | 2017 | 63 | |
| 11 | 2012 | 60 | |
| 12 | 2021 | 57 | |
| 13 | 2020 | 43 | |
| 14 | 2023 | 35 | |
| 15 | 2022 | 30 | |
| 16 | 2019 | 26 | |
| 17 | 2019 | 26 | |
| 18 | 2022 | 24 | |
| 19 | 2019 | 23 | |
| 20 | 2023 | 22 |
About Marc Deloger
Marc Deloger is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers), Immune cells in cancer (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Amoebic Infections and Treatments (3 papers), Genomics and Phylogenetic Studies (2 papers) and Parasitic Infections and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (372 citations), Neurology (190 citations), Oncology (581 citations), Infectious Diseases (407 citations) and Immunology (417 citations). Marc Deloger has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Marie‐Agnès Petit, Meriem El Karoui, Steven C. Le Comber, Richard A. Nichols, Andrew Rowland Leitch, Marie‐Angéle Grandbastien, Michael Chester, Petr Novák, Mark W. Chase and Simon Renny‐Byfield. Their work appears in journals such as Annals of Oncology, Cancer Discovery, Clinical Cancer Research, British Journal of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.